DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/95x2qn/ablation) has announced the addition of the "Ablation Technologies Market by Product, Application - Global Forecasts to 2019" report to their offering.
The market is expected to reach $2.41 billion by 2019, at CAGR of 9.6% from 2014 to 2019
The global ablation technologies market is estimated to grow at a CAGR of 9.6% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the ablation technologies market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 12.8% in the next five years. Factors such as increasing government initiatives for the modernization of healthcare infrastructure, growing number of hospitals and surgical centers, and the rising focus of international and domestic players on the Asia-Pacific ablation technologies market are propelling its growth.
The growth of the ablation technologies market is driven by factors such as ongoing technological development initiatives, rapidly aging population, increasing demand for laparoscopic surgical procedures, modernization of healthcare facilities in emerging countries of the Asia-Pacific and RoW (Rest of the World) regions, and geographic expansions of market players across the globe. However, factors such as ongoing healthcare reforms in the U.S., product recalls, and increasing cost-containment issues faced by ablation device manufacturers and distributors are restraining the growth of this market. Growing number of hospitals and surgical centers, and government initiatives to increase healthcare awareness in developing countries are creating opportunities for the growth of the ablation technologies market.
The global ablation technologies market is highly competitive, with a large number of global and local players. As of 2013, the global ablation technologies market was dominated by Covidien plc (Ireland), Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), which together accounted for -55% of the market. New product launches, pipeline product enhancements, and partnerships, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the ablation technologies market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Global Ablation Technologies Market, By Type
8 Global Ablation Technologies Market, By Product
9 Global Ablation Technologies Market, By Application
10 Ablation Technologies Market, By Geography
11 Competitive Landscape
12 Company Profiles
- Angiodynamics, Inc.
- Atricure, Inc.
- Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
- Boston Scientific Corporation
- Conmed Corporation
- Covidien PLC
- Medtronic, Inc.
- Olympus Corporation
- Smith & Nephew PLC
- St. Jude Medical, Inc.
For more information visit http://www.researchandmarkets.com/research/95x2qn/ablation
